Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients

Table 1 Laboratory data, Child-Pugh and model for end-stage liver disease scores before and after liver transplantation in the patients’ group

Variable	Before LT (median ± IQR)	After LT (median ± IQR)	Z	P value
INR	1.5 ± 0.6	1.4 ± 0.4	2.198	0.0291
ALT (N: 7-40 IU/L)	24.5 ± 35.25	19.5 ± 29.8	2.201	0.0261
AST (N: 7-37 IU/L)	44.5 ± 28	22.5 ± 13.75	2.918	0.0022
Total bilirubin (N: 0.2-1.2 mg/dL)	2 ± 2.45	1.4 ± 0.8	2.156	0.0291
Albumin (N: 3.5-5.3 g/dL)	2.3 ± 1.15	3.3 ± 0.9	3.021	0.0211
Creatinine (N: 0.5-1.2 mg/dL)	0.9 ± 0.4	1 ± 0.2	0.176	0.893
BUN (N: 20-40 mg/dL)	12 ± 6.8	11.5 ± 4.8	0.218	0.839
Sodium (N: 135-147 mEq/L)	132.5 ± 11.75	134.5 ± 10.8	0.197	0.856
Potassium (N: 3.5-5.3 mEq/L)	3.8 ± 0.7	4.4 ± 0.8	2.469	0.0111
Calcium (N: 9-11 mg/dL)	8.6 ± 1.1	8.9 ± 1.3	2.584	0.0072
Phosphorus (N: 3-4.5 mg/dL)	3.2 ± 0.6	3.6 ± 1.3	3.219	< 0.0012
Magnesium (N: 1.8-3.6 mg/dL)	2.1 ± 0.6	2.2 ± 0.7	1.777	0.076
Child-Pugh score	9 ± 4.5	6 ± 1.8	3.549	< 0.0012
MELD score	14.5 ± 6.5	11.5 ± 4.5	2.928	0.0022

¹Significant;

²Highly significant. Z: Wilcoxon signed ranks test; IQR: Inter-quartile range; INR: International normalized ratio; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BUN: Blood urea nitrogen; MELD: Model for end-stage liver disease; LT: Liver transplantation; N: Normal range.